Have a personal or library account? Click to login
Anticoagulation in COVID – 19: An Update Cover

Anticoagulation in COVID – 19: An Update

The Journal of Critical Care Medicine
Volume 6 (2020): Issue 4 (October 2020)
By: Nishant R Tiwari,  Khalid I Khatib,  Subhal B Dixit,  Prajay K Rathore,  Sameer Melinkeri,  Abhijeet Ganapule,  Kapil S Borawake and  Ujwala Mhatre  
Open Access
|Nov 2020

References

  1. Wu F, Zhao S, Yu B, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579(7798):265-269. doi:10.1038/s41586-020-2008-3
    Open DOISearch in Google ScholarBack to article
  2. Bikdeli B, Madhavan M V., Jimenez D, et al. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up. J Am Coll Cardiol. 2020;75(23). doi:10.1016/j.jacc.2020.04.031
    Open DOISearch in Google ScholarBack to article
  3. Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020;135(23):20332040. doi:10.1182/blood.2020006000
    Open DOISearch in Google ScholarBack to article
  4. Grasselli G, Pesenti A, Cecconi M. Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast during an Emergency Response. JAMA - J Am Med Assoc. Published online, 2020. doi:10.1001/jama.2020.4031
    Open DOISearch in Google ScholarBack to article
  5. Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centred, retrospective, observational study. Lancet Respir Med. 2020;8(5):475-481. doi:10.1016/S2213-2600(20)30079-5
    Open DOISearch in Google ScholarBack to article
  6. Bhatraju PK, Ghassemieh BJ, Nichols M, et al. Covid-19 in Critically Ill Patients in the Seattle Region — Case Series. N Engl J Med. Published online 2020:2012-2022. doi:10.1056/nejmoa2004500
    Open DOISearch in Google ScholarBack to article
  7. Engelmann B, Massberg S. Thrombosis as an intravascular efector of innate immunity. Nat Rev Immunol. 2013;13(1):3445. doi:10.1038/nri3345
    Open DOISearch in Google ScholarBack to article
  8. Delabranche X, Helms J, Meziani F. Immunohaemostasis: a new view on haemostasis during sepsis. Ann Intensive Care. 2017;7(1):1-14. doi:10.1186/s13613-017-0339-5
    Open DOISearch in Google ScholarBack to article
  9. Guan W, Ni Z, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708-1720. doi:10.1056/NEJMoa2002032
    Open DOISearch in Google ScholarBack to article
  10. Klok FA, Kruip MJHA, van der Meer NJM, et al. incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191(April):145-147. doi:10.1016/j.thromres.2020.04.013
    Open DOISearch in Google ScholarBack to article
  11. Fox SE, Akmatbekov A, Harbert JL, Li G, Brown JQ. Pulmonary and Cardiac Pathology in Covid-19 : The First Autopsy Series from New Orleans 1 ) Department of Pathology , LSU Health Sciences Center, New Orleans 2 ) Pathology and Laboratory Medicine Service, Southeast Louisiana Veterans Healthcare System 3. medRxiv. Published online, 2020.
    Search in Google ScholarBack to article
  12. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844847. doi:10.1111/jth.14768
    Open DOISearch in Google ScholarBack to article
  13. Klok FA, Kruip MJHA, van der Meer NJM, et al. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis. Thromb Res. 2020;191(April):148-150. doi:10.1016/j.thromres.2020.04.041
    Open DOISearch in Google ScholarBack to article
  14. Al-Samkari H, Karp Leaf RS, Dzik WH, et al. COVID and Coagulation: Bleeding and Thrombotic Manifestations of SARS-CoV2 Infection.; 2020. doi:10.1182/blood.2020006520
    Open DOISearch in Google ScholarBack to article
  15. Cui S, Chen S, Li X, Liu S, Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost. 2020;(April):1421-1424. doi:10.1111/jth.14830
    Open DOISearch in Google ScholarBack to article
  16. Hippensteel JA, Burnham EL, Jolley SE. Prevalence of Venous Thromboembolism in Critically Ill Patients with COVID-19. Br J Haematol. Published online 2020:0-3. doi:10.1111/bjh.16908
    Open DOISearch in Google ScholarBack to article
  17. Helms J, Tacquard C, Severac F, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. Published online, 2020. doi:10.1007/s00134-020-06062-x
    Open DOISearch in Google ScholarBack to article
  18. Llitjos JF, Leclerc M, Chochois C, et al. High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients. J Thromb Haemost. 2020;(April):1-4. doi:10.1111/jth.14869
    Open DOISearch in Google ScholarBack to article
  19. Nahum J, Morichau-Beauchant T, Daviaud F, et al. Venous Thrombosis Among Critically Ill Patients With Coronavirus Disease 2019 (COVID-19). JAMA Netw Open. 2020;3(5):e2010478. doi:10.1001/jamanetworkopen.2020.10478
    Open DOISearch in Google ScholarBack to article
  20. Lippi G, Bonfanti L, Saccenti C, Cervellin G. Causes of elevated D-dimer in patients admitted to a large urban emergency department. Eur J Intern Med. 2014;25(1):45-48. doi:10.1016/j. ejim.2013.07.012
    Open DOISearch in Google ScholarBack to article
  21. Bowles L, Platon S, Yartey N, et al. Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19. N Engl J Med. Published online 2020:1-2. doi:10.1056/nejmc2013656
    Open DOISearch in Google ScholarBack to article
  22. Harzallah I, Debliquis A, Drénou B. Lupus anticoagulant is frequent in patients with Covid-19. J Thromb Haemost. 2020;(April):14867. doi:10.1111/jth.14867
    Open DOISearch in Google ScholarBack to article
  23. Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020;(March):1094-1099. doi:10.1111/jth.14817
    Open DOISearch in Google ScholarBack to article
  24. Wiseman AC. Immunosuppressive medications. Clin J Am Soc Nephrol. 2016;11(2):332-343. doi:10.2215/CJN.08570814
    Open DOISearch in Google ScholarBack to article
  25. Journal EH, Pharmacotherapy C. Figure 1. Published online 2020:1-2. doi:10.1111/jth.14817.6.
    Open DOISearch in Google ScholarBack to article
  26. Thachil J, Tang N, Gando S, et al. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost. 2020;(March):1023-1026. doi:10.1111/jth.14810
    Open DOISearch in Google ScholarBack to article
  27. Spyropoulos AC, Levy JH, Ageno W, et al. Scientific and Standardization Committee Communication: Clinical Guidance on the Diagnosis, Prevention and Treatment of Venous Thromboembolism in Hospitalized Patients with COVID-19. J Thromb Haemost. Published online 2020:0-2. doi:10.1111/jth.14929
    Open DOISearch in Google ScholarBack to article
  28. Barnes GD, Burnet A, Allen A, et al. Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum. J Thromb Thrombolysis. 2020;(0123456789):1-10. doi:10.1007/s11239-020-02138-z
    Open DOISearch in Google ScholarBack to article
  29. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-513. doi:10.1016/S0140-6736(20)30211-7
    Open DOISearch in Google ScholarBack to article
  30. Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA - J Am Med Assoc. 2020;323(11):1061-1069. doi:10.1001/jama.2020.1585
    Open DOISearch in Google ScholarBack to article
  31. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):10541062. doi:10.1016/S0140-6736(20)30566-3
    Open DOISearch in Google ScholarBack to article
  32. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. doi:10.1016/S0140-6736(20)30183-5
    Open DOISearch in Google ScholarBack to article
  33. Chen G, Wu D, Guo W, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020;130(5):2620-2629. doi:10.1172/JCI137244
    Open DOISearch in Google ScholarBack to article
  34. Han H, Yang L, Liu R, et al. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection [published online ahead of print, 2020 Mar 16]. Clin Chem Lab Med. Published online, 2020. doi:10.1515/cclm-2020-0188
    Open DOISearch in Google ScholarBack to article
  35. Li Y, Zhao K, Wei H, et al. Dynamic relationship between D‐ dimer and COVID‐19 severity. Br J Haematol. Published online 2020:bjh.16811. doi:10.1111/bjh.16811
    Open DOISearch in Google ScholarBack to article
  36. Ashjian P, Chen CM, Pusic A, Disa JJ, Cordeiro PG, Mehrara BJ. The effect of postoperative anticoagulation on microvascular thrombosis. Ann Plast Surg. 2007;59(1):36-39. doi:10.1097/01.sap.0000264837.15110.2f
    Open DOISearch in Google ScholarBack to article
  37. Sorg H, Hofmann JO, Hofmann JN, Vollmar B. Analysis of the influence of antithrombin on microvascular thrombosis: anti-inflammation is crucial for anticoagulation. Intensive Care Med Exp. 2015;3(1):22. doi:10.1186/s40635-015-0058-x
    Open DOISearch in Google ScholarBack to article
DOI: https://doi.org/10.2478/jccm-2020-0033 | Journal eISSN: 2393-1817 | Journal ISSN: 2393-1809
Journal RSS Feed
Language: English
Page range: 217 - 223
Submitted on: Jul 14, 2020
Accepted on: Sep 16, 2020
Published on: Nov 7, 2020
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
COVID-19,
anticoagulation,
venous thromboembolism,
SARS-CoV-2,
intensive care unit
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Internal medicine, other,
Surgery,
Surgery, other,
Anaesthesiology,
Emergency medicine and intensive-care medicine

© 2020 Nishant R Tiwari, Khalid I Khatib, Subhal B Dixit, Prajay K Rathore, Sameer Melinkeri, Abhijeet Ganapule, Kapil S Borawake, Ujwala Mhatre, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 6 (2020): Issue 4 (October 2020)Next article